Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections

Diabetic Medicine : a Journal of the British Diabetic Association
A NicolucciE Vitacolonna

Abstract

The aim of this case-control study was to compare quality of life (QoL) and treatment satisfaction in adults with Type 1 diabetes (T1DM) treated with either continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI). Consecutive patients aged between 18 and 55 years, and attending diabetes clinics for a routine visit, completed the Diabetes-Specific Quality-of-Life Scale (DSQOLS), the Diabetes Treatment Satisfaction Questionnaire (DTSQ) and the SF-36 Health Survey (SF-36). Case (CSII) and control subjects (MDI) were recruited in a 1 : 2 ratio. Overall, 1341 individuals were enrolled by 62 diabetes clinics; 481 were cases and 860 control subjects. Cases had a longer diabetes duration and were more likely to have eye and renal complications. Age, school education, occupation and HbA(1c) were similar. Of control subjects, 90% followed glargine-based MDI regimens and 10% used NPH-based MDI regimens. On multivariate analysis, after adjusting for socioeconomic and clinical characteristics, scores in the following areas of the DSQOLS were higher in cases than control subjects: diet restrictions (beta = 5.96; P < 0.0001), daily hassles (beta = 3.57; P = 0.01) and fears about hypoglycaemia (beta = 3.88; P = 0.006...Continue Reading

References

Apr 1, 1990·Controlled Clinical Trials·W D Dupont, W D Plummer
Nov 17, 1998·Journal of Clinical Epidemiology·G Apolone, P Mosconi
Jul 24, 2002·Diabetologia·M Koopmanschap, UNKNOWN CODE-2 Advisory Board
Jul 31, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·D BruttomessoA Tiengo
Sep 27, 2002·Diabetes/metabolism Research and Reviews·Clare Bradley, Jane Speight
Feb 11, 2004·American Journal of Epidemiology·Guan-Hua HuangUNKNOWN Wisconsin Diabetes Registry
Oct 19, 2004·Health Technology Assessment : HTA·J L ColquittN Waugh
Oct 4, 2005·Current Medical Research and Opinion·Ruth E DavisCraig J Currie
Mar 21, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·K D BarnardT C Skinner
Jul 1, 2002·Diabetologia·M Koopmanschap

❮ Previous
Next ❯

Citations

Jul 4, 2012·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·M FranciosiA Nicolucci
Mar 30, 2013·Diabetes Technology & Therapeutics·Britt-Marie CarlssonMarcus Lind
Jun 26, 2012·Journal of Neurosurgery·Nicholas F MarkoRobert J Weil
Mar 23, 2010·Diabetes & Metabolism·J-P RivelineUNKNOWN Groupe Pompe Sud-Francilien
Oct 7, 2015·Journal of Diabetes and Its Complications·Pamela Martyn-NemethLaurie Quinn
Jan 16, 2010·Diabetes & Metabolism·V Lassmann-VagueUNKNOWN Société francophone du diabète (ex ALFEDIAM)
Nov 29, 2014·Medical & Biological Engineering & Computing·Giordano LanzolaRiccardo Bellazzi
Jul 15, 2015·Diabetes Technology & Therapeutics·William H PolonskySteven V Edelman
Aug 30, 2008·The Mount Sinai Journal of Medicine, New York·Jennifer Sherr, William V Tamborlane
Jan 28, 2009·Diabetes/metabolism Research and Reviews·Daniela BruttomessoAldo Baritussio
Mar 23, 2013·Journal of Paediatrics and Child Health·Jessica E PetersMary Anne Silvers
Oct 31, 2013·TheScientificWorldJournal·Francesco RotellaEdoardo Mannucci
Feb 19, 2013·Computer Methods and Programs in Biomedicine·Davide Capozzi, Giordano Lanzola
May 1, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Ayman A Al HayekFahad S Al Sabaan
Sep 15, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·M FranciosiA Nicolucci
Feb 7, 2015·European Journal of Endocrinology·Marcus QuinklerMarianne Øksnes
Mar 3, 2012·Diabetes Research and Clinical Practice·Emily G MoserSatish K Garg
Jan 28, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Meaghan St CharlesMichael E Minshall
Feb 27, 2015·Diabetes Technology & Therapeutics·Katharine D Barnard, Nick Oliver
Jan 27, 2015·Best Practice & Research. Clinical Endocrinology & Metabolism·Marianne ØksnesKristian Løvås
Jul 2, 2016·Indian Journal of Endocrinology and Metabolism·Haider GhazanfarIman Qaiser
Sep 23, 2016·International Journal of Impotence Research·M I MaiorinoK Esposito
Oct 18, 2016·Diabetes Technology & Therapeutics·William H PolonskyHoward Zisser
Jul 16, 2016·Journal of Diabetes Science and Technology·Steven JamesJulia Lowe
Sep 25, 2017·Current Diabetes Reports·Valentina SerranoVictor M Montori
Feb 9, 2018·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Claire ReidyAnne Rogers
Aug 8, 2009·Diabetes/metabolism Research and Reviews·François Pouwer, Norbert Hermanns
Nov 3, 2016·Journal of Diabetes Science and Technology·Steven JamesJulia Lowe
Sep 11, 2016·Journal of Endocrinological Investigation·M I MaiorinoK Esposito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.